Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States.

biologic therapy ileal pouch-anal anastomosis pouchitis

Journal

Crohn's & colitis 360
ISSN: 2631-827X
Titre abrégé: Crohns Colitis 360
Pays: England
ID NLM: 101752188

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 11 03 2020
entrez: 4 8 2020
pubmed: 4 8 2020
medline: 4 8 2020
Statut: ppublish

Résumé

Gaps exist in our understanding of the clinical course of pouch-related disorders. We evaluated baseline disease activity and longitudinal treatment patterns among patients with inflammatory conditions of the pouch. Among 468 patients with an ileal pouch-anal anastomosis (IPAA), 94 (20%) had acute pouchitis, 96 (21%) had chronic pouchitis, and 192 (41%) had Crohn disease of the pouch. Following an IPAA, 38% of patients were treated with a biologic and 11% underwent inflammatory bowel disease- or bowel-related surgery. Treatment patterns after IPAA indicate that pouch-related disorders have a significant impact on individual patients and the healthcare system.

Sections du résumé

BACKGROUND BACKGROUND
Gaps exist in our understanding of the clinical course of pouch-related disorders.
METHODS METHODS
We evaluated baseline disease activity and longitudinal treatment patterns among patients with inflammatory conditions of the pouch.
RESULTS RESULTS
Among 468 patients with an ileal pouch-anal anastomosis (IPAA), 94 (20%) had acute pouchitis, 96 (21%) had chronic pouchitis, and 192 (41%) had Crohn disease of the pouch. Following an IPAA, 38% of patients were treated with a biologic and 11% underwent inflammatory bowel disease- or bowel-related surgery.
CONCLUSIONS CONCLUSIONS
Treatment patterns after IPAA indicate that pouch-related disorders have a significant impact on individual patients and the healthcare system.

Identifiants

pubmed: 32744536
doi: 10.1093/crocol/otaa039
pii: otaa039
pmc: PMC7380550
doi:

Types de publication

Journal Article

Langues

eng

Pagination

otaa039

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK034987
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.

Références

Inflamm Bowel Dis. 2019 Aug 20;25(9):1569-1576
pubmed: 30810748
J Gastrointest Surg. 2019 Mar;23(3):571-579
pubmed: 30097964
Therap Adv Gastroenterol. 2016 Sep;9(5):664-70
pubmed: 27582878
Dis Colon Rectum. 2013 Jun;56(6):733-7
pubmed: 23652747
Inflamm Bowel Dis. 2019 Mar 14;25(4):767-774
pubmed: 30295784
Colorectal Dis. 2012 Nov;14(11):1365-71
pubmed: 22339717
Inflamm Bowel Dis. 2020 Jun 18;26(7):1079-1086
pubmed: 31587035
Gut. 2001 Nov;49(5):671-7
pubmed: 11600470
Clin Gastroenterol Hepatol. 2008 May;6(5):561-8
pubmed: 18378498
BJS Open. 2019 Mar 13;3(4):436-444
pubmed: 31463422
Inflamm Bowel Dis. 2019 Feb 21;25(3):460-471
pubmed: 30124882
Ann Surg. 2000 Jun;231(6):919-26
pubmed: 10816636
Dis Colon Rectum. 2018 Aug;61(8):920-930
pubmed: 29944583
Ann Surg. 2003 Aug;238(2):229-34
pubmed: 12894016
Aliment Pharmacol Ther. 2017 Mar;45(5):581-592
pubmed: 28008631
Inflamm Bowel Dis. 2017 May;23(5):781-790
pubmed: 28301429
Clin Gastroenterol Hepatol. 2020 May;18(6):1356-1366
pubmed: 31589972
Dis Colon Rectum. 2012 Mar;55(3):330-6
pubmed: 22469801
Inflamm Bowel Dis. 2015 Jan;21(1):208-20
pubmed: 25222665
Aliment Pharmacol Ther. 2013 May;37(9):867-75
pubmed: 23480145
Dis Colon Rectum. 2019 Nov;62(11):1344-1351
pubmed: 31596761
J Clin Gastroenterol. 2015 Sep;49(8):647-54
pubmed: 26084005
Aliment Pharmacol Ther. 2017 Jul;46(2):162-168
pubmed: 28470787
Aliment Pharmacol Ther. 2018 Feb;47(3):364-370
pubmed: 29164650
Aliment Pharmacol Ther. 2015 Jun;41(11):1066-78
pubmed: 25855078
Clin Gastroenterol Hepatol. 2015 Jun;13(6):1197-200
pubmed: 25460565
J Crohns Colitis. 2014 Jul;8(7):662-70
pubmed: 24418660
Inflamm Bowel Dis. 2020 Jul 17;26(8):1225-1231
pubmed: 31634390
Aliment Pharmacol Ther. 2017 Sep;46(5):508-515
pubmed: 28664992
Nat Rev Gastroenterol Hepatol. 2012 Apr 17;9(6):323-33
pubmed: 22508158
Inflamm Bowel Dis. 2018 Nov 29;24(12):2634-2640
pubmed: 29788063
Dis Colon Rectum. 2008 May;51(5):554-60
pubmed: 18266037
Inflamm Bowel Dis. 2018 Jan 18;24(2):261-268
pubmed: 29361101
Inflamm Bowel Dis. 2017 Jul;23(7):1218-1224
pubmed: 28426474
Dis Colon Rectum. 2003 Jun;46(6):748-53
pubmed: 12794576
Inflamm Bowel Dis. 2019 Aug 20;25(9):1474-1480
pubmed: 30698715
Dis Colon Rectum. 2017 Nov;60(11):1201-1208
pubmed: 28991085

Auteurs

Edward L Barnes (EL)

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.
Multidisciplinary Inflammatory Bowel Diseases Center, University of North Carolina, Chapel Hill, North Carolina, USA.

Laura Raffals (L)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Millie D Long (MD)

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.
Multidisciplinary Inflammatory Bowel Diseases Center, University of North Carolina, Chapel Hill, North Carolina, USA.

Gaurav Syal (G)

Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Maia Kayal (M)

The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Ashwin Ananthakrishnan (A)

Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Benjamin Cohen (B)

The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Joel Pekow (J)

Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago, Chicago, Illinois, USA.

Parakkal Deepak (P)

Washington University Inflammatory Bowel Diseases Center, St. Louis, Missouri, USA.

Jean-Frederic Colombel (JF)

The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Hans H Herfarth (HH)

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.
Multidisciplinary Inflammatory Bowel Diseases Center, University of North Carolina, Chapel Hill, North Carolina, USA.

Robert S Sandler (RS)

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.

Classifications MeSH